UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Roche’s breast cancer drug gains more insurance benefits
by Lee Han-soo
2019-05-21 10:44
Low-income, single women more vulnerable to osteoporosis
by Kim Yun-mi
2019-05-20 15:40
Bridge Biotherapeutics releases first-in-human study for idiopathic pulmonary fibrosis treatment
by Lee Han-soo
2019-05-20 15:29
Hospital beds going up in Korea contrary to OECD's trend
by Song Soo-youn
2019-05-20 15:19
Regulator inspecting Kolon TissuGene in US this week
by Lee Hye-seon
2019-05-20 14:22
라인
'Yuyu should – and will -- be reborn as new drug developer'
by Lee Han-soo
2019-05-17 17:11
[Pre-ASCO 2019] Samsung Bioepis: Ontruzant - HER2-positive breast cancer treatment
by Lee Han-soo
2019-05-17 16:19
[Special] Is Watson hype cooling down?
by Kim Eun-young
2019-05-17 15:40
Kolon to follow 3,700 Invossa-treated patients for 15 years
by Jeong Sae-im
2019-05-17 15:38
GC MS to supply glycated hemoglobin monitoring system to Japan
by Lee Han-soo
2019-05-17 14:37
라인
Saxenda's sales surge 3,000 times yoy in Q1
by Lee Han-soo
2019-05-17 14:37
Will Celltrion CEO’s bet on ‘bio valley’ pay off?
by Jeong Sae-im
2019-05-17 13:21
[Pre-ASCO 2019] Yuhan: Lazertinib -- non-small cell lung cancer treatment
by Lee Han-soo
2019-05-17 09:57
Daewoong launches Nabota in US amid controversy
by Lee Han-soo
2019-05-16 16:33
Medical IT changes China's healthcare landscape
by Song Soo-youn
2019-05-16 16:33
라인
Inhibiting PMVK can increase cancer radiation therapy efficacy
by Lee Han-soo
2019-05-16 15:40
CHA Biotech’s operating income plunges 92% in Q1
by Jeong Sae-im
2019-05-16 13:41
KangStem Biotech completes stem cell drug plant
by Jeong Sae-im
2019-05-16 11:27
Severance succeeds in 1st heart transplant to Behcet's disease patient
by Lee Han-soo
2019-05-15 17:48
SNUH administers first dose of Spinraza in Korea
by Lee Han-soo
2019-05-15 16:00
-
이전
121
122
123
124
125
126
127
128
129
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top